BitMine Immersion (BMNR) stock jumps as Tom Lee presses for a 50 billion-share vote
4 January 2026
2 mins read

BitMine Immersion (BMNR) stock jumps as Tom Lee presses for a 50 billion-share vote

NEW YORK, January 4, 2026, 11:34 ET — Market closed

  • BitMine shares last traded up about 15% after the company pushed shareholders to back a sweeping increase in authorized shares. 1
  • The proposal would lift the authorized share cap to 50 billion, with voting due by Jan. 14 ahead of a Jan. 15 annual meeting in Las Vegas. 2
  • Investors are weighing added financing flexibility against dilution risk in a stock that the company says has tracked ether since a midyear strategy pivot. 2

Shares of NYSE American-listed BitMine Immersion Technologies (BMNR) were last up about 15% at $31.19, after the company released fresh materials from Chairman Tom Lee urging shareholders to approve a major increase in authorized shares. 1

The vote matters now because BitMine is asking investors to expand the ceiling on how many shares it can issue — known as “authorized shares” — from 500 million to 50 billion. The company has roughly 426 million shares outstanding, close to the current cap cited in its materials. 2

BitMine has pitched the change as a tool for financing and equity management as it leans into an ether-focused treasury strategy. The company told shareholders its stock has closely tracked ether, the token of the Ethereum blockchain, since it pivoted to make ether its primary treasury asset. 2

In an SEC filing on Friday, BitMine said it published a presentation and released a video — along with a written transcript — centered on the charter amendment proposal to increase authorized shares. A separate filing attached a press release encouraging shareholders to vote “FOR” the proposal. 1

“I want to ask you to vote yes for the authorized shares increase,” Lee said in the transcript. 3

BitMine traded between $27.48 and $31.50 in the last session, with about 58 million shares changing hands. The stock was last at $31.19.

The annual meeting is scheduled for Jan. 15 at the Wynn Las Vegas, and shareholders have until 11:59 p.m. ET on Jan. 14 to submit votes via internet or telephone, the company’s proxy materials show. Alongside the charter amendment, investors will also vote on director elections and proposals tied to an omnibus incentive plan and an executive chairman compensation arrangement. 2

Lee said the expanded authorization would support capital markets activity, including at-the-market offerings — programs that sell new shares into the open market — as well as convertibles and warrants, and would provide flexibility for acquisitions. He also said the higher cap would accommodate future stock splits, which increase the share count while reducing the price per share. 2

But an expanded authorization also gives the company more room to issue stock, which can dilute existing shareholders if used heavily. The charter amendment requires approval by a majority of outstanding shares, and the company’s own messaging ties the stock’s appeal to crypto-price moves — a source of both upside and sharp drawdowns. 4

Other crypto-linked U.S. equities also rose in the last session, including Strategy (MSTR), up about 3.5%, and bitcoin miners Marathon Digital (MARA) and Riot Platforms (RIOT), up roughly 10% and 12%, respectively.

Technically, traders will watch whether BMNR holds above $30 after Friday’s spike, with the session high near $31.50 as the next upside marker and the $27.50 area — near the day’s low — as a near-term downside level.

With U.S. markets reopening Monday, investors will look for any further disclosures or shareholder-vote messaging ahead of the Jan. 14 deadline and the Jan. 15 meeting. Broader risk appetite could also be tested by Monday’s ISM manufacturing report and Friday’s U.S. jobs data. 2

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
GE Vernova stock jumps nearly 4% to start 2026 as AI-power trade rebounds
Previous Story

GE Vernova stock jumps nearly 4% to start 2026 as AI-power trade rebounds

Exxon stock today: Venezuela shake-up and OPEC+ decision put XOM in focus for Monday
Next Story

Exxon stock today: Venezuela shake-up and OPEC+ decision put XOM in focus for Monday

Go toTop